Impax Announces Sale of Daraprim to Turing Pharmaceuticals AG , ~$55M
August 10, 2015 at 06:34 AM EDT
Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that it has sold its U.S. rights to the Daraprim brand to Turing Pharmaceuticals ...